IPOGrid
0001137883
IPO filing research

BRAINSTORM CELL THERAPEUTICS INC.

Biological Products, (No Diagnostic Substances) · BCLI

follow-on filed OTC S-1

BRAINSTORM CELL THERAPEUTICS INC. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-05-21. Current deal snapshot: exchange OTC.

Filing Timeline

SEC EDGAR
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
25,536,000 shares · Gross proceeds $22,589,000
Class A · Ticker BCLI · July 2023 Warrants and pre-funded warrants · Use of proceeds Proceeds will be used for general corporate purposes
2026-05-21 · 0001104659-26-064628
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows EFFECT and ends the active registration process.
2025-07-22 · 0001104659-25-069626
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-09-27 · 9999999995-24-002998
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-09-06 · 9999999995-24-002744
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2024-06-28 · 0001104659-24-076128
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $8,000,000 · Gross proceeds $8,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Underwriters Raymond James & Associates, Inc.
2024-06-27 · 0001104659-24-075416
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Gross proceeds $14,389,024
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Underwriters Raymond James & Associates, Inc.
2024-04-02 · 0001104659-24-042536
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $1.85 · 4,054,055 shares · Gross proceeds $7,500,001
Common Stock · Exchange NASDAQ · Ticker BCLI · Warrants to purchase up to 4,054,055 shares of Common Stock at $2.00 per share · Use of proceeds Proceeds will be used for general corporate purposes and expenses · Flags warrants, best_efforts · Underwriters Maxim Group LLC
2023-07-19 · 0001104659-23-082222
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2021-08-19 · 9999999995-21-003250
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Gross proceeds $45,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Use of proceeds for general corporate purposes, including working capital and research and development · Underwriters SVB Leerink LLC, Raymond James & Associates, Inc.
2020-09-25 · 0001104659-20-108908
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2,458,201 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Selling stockholders only · Use of proceeds Proceeds will be received by selling stockholders, with no proceeds to the company
2020-08-07 · 0001104659-20-092037
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
842,000 shares
Common · Exchange Nasdaq Capital Market · Ticker BCLI · Warrants held by Warberg WF VII LP (42,000 warrants) are referenced but not part of this offering · Selling stockholders only · Use of proceeds Selling stockholders are offering shares, and the company will not receive any proceeds
2020-06-26 · 0001104659-20-077518
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2,458,201 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Includes warrants held by selling securityholders · Selling stockholders only · Use of proceeds Proceeds will go to the selling stockholders, with no proceeds to the issuer · Flags warrants
2020-06-26 · 0001104659-20-077514
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
common stock, par value $0.00005 per share · Exchange Nasdaq Capital Market · Ticker BCLI · Underwriters Raymond James & Associates, Inc.
2020-03-06 · 0001104659-20-030254
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
1,250,000 shares · Gross proceeds $10,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Common Stock and Warrant · Warrant for 250,000 shares with $15 exercise price, exercisable immediately, 3-year term
2020-03-06 · 0001104659-20-030108
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B1 and marks the registration effective.
2019-08-30 · 9999999995-19-002000
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows 424B3 and confirms the priced prospectus.
842,000 shares
Common Stock · Exchange Nasdaq · Ticker BCLI · New Warrants exercisable at $7.00 per share, exercisable from February 3, 2020, expiring December 31, 2021 · Selling stockholders only · Use of proceeds The Company will receive the exercise price for any warrants that are exercised
2019-08-30 · 0001144204-19-043045
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
842,000 shares · Gross proceeds $3,300,000
Common Stock · Exchange NASDAQ · Ticker BCLI · Warrants to purchase 842,000 shares at $7.00, expiring 12/31/2021 · Flags warrants
2019-08-02 · 0001144204-19-037507
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $20,000,000 · Gross proceeds $20,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Underwriters Raymond James & Associates, Inc.
2019-06-11 · 0001144204-19-030587
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B1 and marks the registration effective.
2018-09-28 · 9999999995-18-002494
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2,458,201 shares
common · Exchange Nasdaq Capital Market · Ticker BCLI · New Warrants exercisable at $9.00 per share expiring 12/31/2020 · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be received by the company, but no proceeds from the sale of securities by the selling stockholders · Flags warrants
2018-09-28 · 0001144204-18-051595
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2018-06-29 · 9999999995-18-001675
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
3,858,201 shares · Gross proceeds $12,300,000
Common · Exchange Nasdaq Capital Market · Ticker BCLI · Warrants exercisable at $5.00 per share, with new warrants issued upon exercise · Selling stockholders only · Use of proceeds Gross proceeds to the company from warrant exercises
2018-06-07 · 0001144204-18-033160
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-11-21 · 9999999995-16-006279
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock and Warrants · Exchange Nasdaq Capital Market · Ticker BCLI · Each Unit consisting of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 warrant per unit · Selling stockholders only · Use of proceeds Proceeds to selling stockholders, no issuer proceeds
2016-08-12 · 0001144204-16-118440
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant · 0.75 Warrant per Share · Selling stockholders only · Flags units, warrants
2016-05-10 · 0001144204-16-100361
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common · Exchange NASDAQ · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 Warrant per Unit to purchase one Share of Common Stock · Selling stockholders only · Use of proceeds For working capital, research and development, and general corporate purposes · Flags foreign_private_issuer
2016-05-10 · 0001144204-16-100355
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common · Exchange NASDAQ · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 of a Warrant to Purchase One Share of Common Stock per Unit · Selling stockholders only · Use of proceeds Proceeds will be used by the selling stockholders
2015-11-17 · 0001144204-15-066288
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Each Unit consists of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Warrants to purchase common stock · Selling stockholders only · Use of proceeds Proceeds will be received by selling stockholders, with no proceeds to the company · Flags units, warrants
2015-08-13 · 0001144204-15-048827
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2015-06-10 · 9999999995-15-001597
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2015-05-27 · 9999999995-15-001456
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
common_stock · Exchange Nasdaq · Ticker BCLI · Each Unit consisting of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Each Unit includes 0.75 of a Warrant to Purchase One Share of Common Stock · Selling stockholders only
2015-05-18 · 0001144204-15-031957
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange Nasdaq · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only · Use of proceeds Proceeds will be used for general corporate purposes
2015-05-18 · 0001144204-15-031955
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2015-05-01 · 9999999995-15-001141
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
COMMON · Exchange NASDAQ · Ticker BCLI · Each Unit consisting of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 warrants per unit · Selling stockholders only
2015-03-26 · 0001144204-15-018697
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only · Use of proceeds Proceeds will go to selling stockholders, no proceeds to the issuer
2015-03-26 · 0001144204-15-018693
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
84,000,000 shares
Common Stock · Exchange NASDAQ · Ticker BCLI · Selling stockholders only
2015-03-26 · 0001144204-15-018688
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2015-02-10 · 9999999995-15-000369
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B1 and marks the registration effective.
2015-02-10 · 9999999995-15-000368
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows 424B1 and confirms the priced prospectus.
3,858,201 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Warrants exercisable at $6.50 per share, expiring June 19, 2018 · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be received by the company, with no proceeds to the company from the resale of shares
2015-02-10 · 0001144204-15-007452
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows 424B3 and confirms the priced prospectus.
3,937,127 shares · Gross proceeds $0.00
Common · Exchange Nasdaq Capital Market · Ticker BCLI · ACCBT Warrants exercisable at $3.00 and $4.35 per share, expiring November 5, 2017 · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes
2015-02-10 · 0001144204-15-007447
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $5.22 · 84,000,000 shares · Gross proceeds $13,000,000
Common Stock · Exchange NASDAQ · Ticker BCLI · Exercised 2014 Warrants (2.5M shares at $5.22) and issued New Warrants (3.8M shares at $6.50) · Use of proceeds Proceeds from warrant exercises used for general corporate purposes · Flags warrants · Underwriters Maxim Group LLC
2015-01-08 · 0001144204-15-001394
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange NASDAQ · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock, with 14,864,229 shares underlying the warrants
2014-11-13 · 0001144204-14-067532
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Each Unit includes 0.75 of a Warrant to purchase one Share of Common Stock · Selling stockholders only · Use of proceeds Proceeds from the sale of securities will be received by selling stockholders · Flags warrants
2014-11-13 · 0001144204-14-067529
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 8-A12B and confirms the priced prospectus.
84,000,000 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker BCLI · Selling stockholders only · Use of proceeds Proceeds will be received by the selling stockholders.
2014-11-13 · 0001144204-14-067527
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows 424B3 and registers the class of securities for exchange listing.
2014-09-24 · 0001144204-14-057522
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.29 · 19,818,972 shares · Gross proceeds $2,628,000
Common Stock, $0.00005 par value · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Use of proceeds For the 2014 Stock Incentive Plan and 2014 Global Share Option Plan
2014-08-27 · 0001144204-14-052681
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.29 · 23,529,411 shares · Gross proceeds $6,871,285
Common · Exchange OTCQB · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 Warrant per Unit · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2014-08-27 · 0001144204-14-052678
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
9,000,000 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Use of proceeds Proceeds to be used for the 2014 Stock Incentive Plan and 2014 Global Share Option Plan
2014-08-27 · 0001144204-14-052675
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only · Flags warrants
2014-08-12 · 0001144204-14-048777
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Each Unit includes 0.75 of a Warrant to Purchase One Share of Common Stock · Selling stockholders only · Use of proceeds Proceeds from the sale of securities will be received by selling stockholders
2014-08-12 · 0001144204-14-048773
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
84,000,000 shares
Common Stock of Brainstorm Cell Therapeutics Inc. · Exchange OTCQB · Ticker BCLI · Selling stockholders only
2014-08-12 · 0001144204-14-048771
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B1 and marks the registration effective.
2014-07-24 · 9999999995-14-002230
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows S-1 and confirms the priced prospectus.
84,000,000 shares · Gross proceeds $0.00
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants exercisable at $0.348 per warrant for one share of common stock · Selling stockholders only · Use of proceeds None, as the company does not receive any proceeds from the sale of these securities
2014-07-24 · 0001144204-14-044693
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.36 · 84,000,000 shares
Common Stock, $.00005 par value per Share · Exchange OTCQB · Ticker BCLI · Warrants exercisable at $0.348 per warrant, up to 42,000,000 shares issuable on exercise · Selling stockholders only · Use of proceeds No issuer proceeds; selling stockholders resell shares
2014-07-10 · 0001144204-14-042335
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only
2014-05-13 · 0001144204-14-029933
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Each Unit consisting of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Each Unit includes 0.75 warrants to purchase one share of Common Stock · Flags units, warrants
2014-05-13 · 0001144204-14-029928
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only
2014-03-28 · 0001144204-14-018515
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Each Unit consists of One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Warrants are not listed on any exchange and no public trading market is expected · Flags units, warrants
2014-03-28 · 0001144204-14-018512
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common · Exchange OTCQB · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · Each unit includes 0.75 of a warrant to purchase one share of common stock · Selling stockholders only · Flags units, warrants
2013-11-14 · 0001144204-13-061909
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only · Use of proceeds Proceeds will be received by selling stockholders, with no proceeds to the company
2013-11-14 · 0001144204-13-061898
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
23,529,411 shares
Common Stock · Ticker BCLI · One Share of Common Stock and 0.75 of a Warrant to Purchase One Share of Common Stock · 0.75 Warrant to Purchase One Share of Common Stock per Unit · Flags units, warrants
2013-08-16 · 0001144204-13-046599
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only
2013-08-16 · 0001144204-13-046597
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common · Exchange OTCQB · Ticker BCLI · Warrants to Purchase 14,864,229 Shares of Common Stock · Selling stockholders only · Use of proceeds Proceeds will go to selling stockholders · Flags warrants
2013-08-16 · 0001144204-13-046589
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only · Use of proceeds Proceeds will be distributed to the selling stockholders.
2013-08-16 · 0001144204-13-046585
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only
2013-08-16 · 0001144204-13-046581
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B1 and confirms the priced prospectus.
19,818,972 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase 14,864,229 shares of common stock · Selling stockholders only
2013-08-16 · 0001144204-13-046573
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $0.17 · 23,529,411 shares · Gross proceeds $3,740,000
Common Stock · Exchange OTCQB · Ticker BCLI · Each Unit consists of one Share of Common Stock and 0.75 Warrant to Purchase One Share of Common Stock · Warrants exercisable at $0.25 per share, expiring 3 years from issuance · Use of proceeds Proceeds will be used for general corporate purposes · Flags units, warrants · Underwriters Roth Capital Partners, Maxim Group LLC
2013-08-13 · 0001144204-13-045242
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows FWP and marks the registration effective.
2013-08-12 · 9999999995-13-002381
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
par value $0.0005 per share · warrants to purchase shares of common stock · Use of proceeds not specified in the filing
2013-08-07 · 0001144204-13-043687
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
16,000,000 shares
common · Exchange OTCQB · Ticker BCLI · Each Unit consists of one share of common stock and 0.75 of a warrant to purchase one share of common stock · Warrants exercisable at $[*] per share, 30-month term, immediately exercisable · Underwriters Roth Capital Partners, Maxim Group LLC
2013-08-06 · 0001144204-13-043084
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Gross proceeds $15,000,000
Common Stock · Exchange OTCQB · Ticker BCLI · Each Unit Consisting of One Share of Common Stock and [ ] of a Warrant, each to Purchase One Share of Common Stock · Warrants exercisable at $[*] per share, expiring on the [*] anniversary of the issuance date · Use of proceeds Use of proceeds not explicitly detailed in provided text · Flags units, warrants · Underwriters Roth Capital Partners, Maxim Group LLC
2013-07-09 · 0001144204-13-038773
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Gross proceeds $15,000,000
Common Stock, $0.00005 par value · Exchange OTCQB Marketplace · Ticker BCLI · One share of common stock and one warrant to purchase one share of common stock · Warrants to purchase one share of common stock at an exercise price of $[*] per share, exercisable immediately and expiring on the [*] anniversary of the issuance date · Flags units, warrants · Underwriters Roth Capital Partners, Maxim Group LLC
2013-06-12 · 0001144204-13-034520
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Common stock, $0.00005 par value · Exchange OTCQB · Ticker BCLI · Warrants to purchase up to [ ] shares of common stock
2013-05-13 · 0001144204-13-028350
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Common Stock; Warrants to Purchase Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase common stock with exercise price of $[___] per share · Use of proceeds For general corporate purposes
2013-03-20 · 0001144204-13-016474
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B1 in the pre-IPO sequence.
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase common stock with an exercise price of $[___] per share · Use of proceeds General corporate purposes
2013-02-08 · 0001144204-13-006961
424B1 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $0.29 · 19,818,972 shares · Gross proceeds $5,747,502
Common · Exchange OTCQB · Ticker BCLI · Warrants to purchase 0.75 shares per share · Warrants to purchase 0.75 shares at $0.29 per share with 30-month term · Flags warrants · Underwriters Maxim Group LLC
2012-07-19 · 0001144204-12-040129
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2012-07-13 · 9999999995-12-002154
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
30,000,000 shares
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase up to 22,500,000 shares of common stock with an exercise price of $[___] per share and a 30-month term · Use of proceeds Proceeds will be used for general corporate purposes · Flags warrants · Underwriters Maxim Group LLC
2012-07-10 · 0001144204-12-038881
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Range $0.24 to $0.24 · 30,000,000 shares · Gross proceeds $12,600,000
Common stock, $0.00005 par value · Exchange OTCQB · Ticker BCLI · Warrants to purchase up to 22,500,000 shares of common stock with an exercise price of $[___] per share · Use of proceeds Proceeds will be used for general corporate purposes · Underwriters Maxim Group LLC
2012-06-29 · 0001144204-12-037444
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Gross proceeds $10,000,000
Common stock, $0.00005 par value; Warrants to purchase shares of common stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase up to [___] shares of common stock at $[___] per share · Use of proceeds Proceeds will be used for general corporate purposes · Flags warrants
2012-05-17 · 0001144204-12-030249
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2012-03-22 · 0001144204-12-016623
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1/A in the pre-IPO sequence.
Common Stock · Exchange OTCQB · Ticker BCLI · Warrants to purchase up to [___] shares at $[___] per share · Use of proceeds Working capital and general corporate purposes
2012-02-03 · 0001144204-12-005706
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
1,600,000 shares
Common Stock · Selling stockholders only · Use of proceeds Resale of shares by selling shareholders
2003-03-03 · 0001022106-03-000016
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $0.04 · Range $0.04 to $0.04 · 1,600,000 shares · Gross proceeds $60,000
Common Stock · Exchange NASDAQ · Selling stockholders only · Use of proceeds None of the proceeds from the sale of stock in this offering will be available to Wizbang Technologies Inc.
2001-08-17 · 0001015402-01-502449
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $0.04 · 1,600,000 shares · Gross proceeds $60,000
Common Stock · Exchange NASDAQ · Selling stockholders only · Use of proceeds None of the proceeds will be available to the company · Flags foreign_private_issuer
2001-07-25 · 0001015402-01-501922
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $0.04 · Range $0.04 to $0.04 · 1,600,000 shares
Common · Exchange NASDAQ · Selling stockholders only · Use of proceeds Proceeds will be received by selling stockholders, none to the company
Wizbang Technologies Inc. is a development-stage company focused on distributing a Digital Data Recorder product line under a licensing agreement with Reach Technologies Inc. The company has no revenue, minimal operations, and relies on a single license for its business plan. The filing outlines financial statements showing a net loss of $9,526 as of March 31, 2001, with cash reserves of $53,474. The offering involves 1.6 million common shares for resale by existing shareholders, with no proceeds benefiting the company. The prospectus highlights significant risks, including dependence on a single license, lack of market penetration, and uncertainty about future profitability.
2001-06-18 · 0001015402-01-501557
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $0.04 · 1,600,000 shares · Gross proceeds $60,000
Common Stock · Exchange NASDAQ · Selling stockholders only · Use of proceeds No proceeds will be available to the company · Flags foreign_private_issuer
Wizbang Technologies Inc. is registering 1.6 million shares of common stock for resale by current shareholders. The company has no operating history, no public market for its stock, and is in early development stages. The offering is not underwritten, and proceeds will not benefit the company. The filing highlights significant risks related to market penetration, dependence on a single individual, supplier relationships, and potential dilution.
2001-05-24 · 0001015402-01-501410
Comparable Deals

14 comparable deals

Healthcare & BiotechMicro (<$50M)Last 18 months
Only 0 strict matches; expanded to 14 using nearest neighbors.
Showing top 8 by similarity.
-0.3%
Median day-1
50%
Above issue
-3.0%
Median week-1
-20.9%
Downside (p10)
Radiopharm Theranostics Ltd RADX
2024-12-05 $19M Day 1: +215.5% Wk 1: +2.3%
same SIC groupsimilar deal sizerecent IPO
Aardvark Therapeutics, Inc. AARD
2026-02-06 $94M Day 1: -20.9% Wk 1: -23.3%
same SIC grouprecent IPO
Odyssey Therapeutics, Inc. ODTX
2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%
same SICrecent IPO
Hemab Therapeutics Holdings, Inc. COAG
2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%
same SICrecent IPO
Functional Brands Inc. MEHA
2025-11-05 $6M Day 1: -35.3% Wk 1: -85.4%
same SIC grouprecent IPO
Agomab Therapeutics NV AGMB
2026-02-06 $200M Day 1: -8.4% Wk 1: -2.1%
same SICrecent IPO
Eikon Therapeutics, Inc. EIKN
2026-02-05 $381M Day 1: -16.7% Wk 1: -19.5%
same SICrecent IPO
Seaport Therapeutics, Inc. SPTX
2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.